BioSpace News Archive

Akeso, Inc (9926.HK) - a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide - today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for AK104, a novel anti-PD-1/CTLA

Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the JMP Securities CNS Forum on August 19, 2020 at 10:30 a.m. Eastern Time. This event will be held virtually. The presentation will be webcast and accessible on a live and archived basis through the investor relations

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that it has been performing user testing with human subjects in Vancouver, BC with its version 2.0 THC Breath Analyzer (“THCBA”)

PostProcess Technologies Inc., the first and only global provider of automated and intelligent post-printing solutions for industrial 3D printing, has announced another patent granted in the United States. U.S. Patent No. 10,737,440, “

Neogen Corporation (Nasdaq: NEOG) announced today that its BioSentry ® 904 Disinfectant has been proven effective by the U.S. Environmental Protection Agency (EPA) to kill the virus that causes COVID-19, SARS-CoV-2, when used according to revised label instructions. BioSentry 904 Disinfectant is a hospital-grade-, broad-spectru

Neovasc, Inc., provided a corporate update on progress towards its value creation strategies.

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics 2.0 and MedTech Innovations Virtual Summit on Thursday, August 13, 2020 , at 3:30 p.m. ET . A live webcast of BD’s presentation can be accessed from the BD corporate website

ViaCyte, Inc. , a clinical stage regenerative medicine company, today announced the appointment of Manasi Sinha Jaiman , M.D., M.P.H. as Vice President, Clinical Development. Dr. Jaiman joins ViaCyte from Covance Clinical Development Services, where she was Senior Medical Director. She was also an attending physician at Harvard Medica

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that it and partner OntoChem have identified additional candidates through their in silico screening study. In addition to four compounds that target an endoribonuclease (als

Madison Core Laboratories announced the launch of a company-wide initiative to become the most innovative diagnostic testing company in the region and provide unsurpassed testing services to better serve clients.